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Background
A recent analysis of mutational patterns within Gag
revealed independently evolving groups of residues (termed
sectors) whose mutations are collectively coordinated.
Of these sectors, sector 3 is the least tolerant of multiple
simultaneous mutations and therefore is proposed to be
the most vulnerable to a targeted immune attack. We
hypothesized that coordinated CTL targeting of sector
3 residues is associated with immune control.
Methods
We completed a comprehensive evaluation of Gag-specific
responses in a cohort of 9 Long-term non-progressors
(LTNPs, VL <2000 RNA copies/ml, untreated) and 9 HIV
progressors (VL>10,000 RNA copies/ml, untreated).
A Gag peptide set of 11-mer peptides overlapping by
10 amino acids was generated to reflect all variants found
in at least 5% of clade B sequences in the LANL HIV
Sequence Database. This peptide set includes 1300 pep-
tides and covers all 500 amino acids of Gag. All study sub-
jects were screened for responses to all peptides by IFN-g/
IL-2 FluoroSpot.
Results
We observed a trend in the preferential targeting of sector
3 residues by LTNPs (p=0.07). This trend was not
observed for any other sector or in total breadth of
responses. Supporting the importance of sector 3 target-
ing, we found a significant positive correlation in our
cohort between the relative proportion of sector
3 responses and CD4 count (r=0.49, p=0.04). We found
no significant differences between LTNPs and HIV-
Progressors in either the targeting of conserved 11-mers
or overall Gag epitope variant recognition. Interestingly,
LTNPs demonstrated higher levels of variant recognition
than HIV-progressors when considering only the variable
regions containing sector 3 residues.
Conclusion
We found that preferential targeting of sector 3 residues
distinguished Gag-specific responses between LTNPs
and HIV-progressors, and that coordinated targeting of
sector 3 residues may require cross-reactive responses.
Additional investigations are ongoing to elucidate the
role of sector 3 targeting in immune control of HIV.
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